|
The buzz: Pharma.
Populations are aging. Chronic diseases are increasing, with new strains emerging at an alarming rate. For these reasons and more, global healthcare costs are skyrocketing and pressure is mounting to develop innovative pharmaceutical drugs. How can pharma organizations accelerate R&D – without compromising quality – to deliver new therapies that effectively fight complex, life-threatening illnesses like cancer? Is technology the key to improving patient outcomes while reducing costs?
The experts speak.
Ashish Goel, Infosys: “We cannot solve problems by using the same kind
|
